SMTL ID : 4k3j.1

Crystal structure of Onartuzumab Fab in complex with MET and HGF-beta

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain B: Y.3, Q.4, L.5, N.7 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:L.5, B:N.7

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Merchant, M. et al., Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent. Proc.Natl.Acad.Sci.USA (2013)

Release Date

2013-08-28

Peptides

Hepatocyte growth factor: A
Hepatocyte growth factor beta chain: B
Onartuzumab Fab heavy chain: C
Onartuzumab Fab light chain: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
H

D
L

Hepatocyte growth factor

Hepatocyte growth factor beta chain

Onartuzumab Fab heavy chain

Onartuzumab Fab light chain

Related Entries With Identical Sequence